ClinicalTrials.Veeva

Find clinical trials for Triple Negative Breast Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma

Triple Negative Breast Cancer trials near Nashville, TN, USA:

CD40 Agonist, Flt3 Ligand, and Chemotherapy in Triple Negative Breast Cancer

doxorubicin (PLD, Doxil) are safe and effective at controlling the cancer in patients with metastatic triple negative breast...

Enrolling
Metastatic Triple Negative Breast Cancer
Drug: CDX-1140
Drug: PLD Chemotherapy

Phase 1

The University of Texas System (UT)
The University of Texas System (UT)

Nashville, Tennessee, United States and 5 other locations

This randomized phase II trial studies how well carboplatin with or without atezolizumab works in treating patients with stage IV triple negative...

Active, not recruiting
HER2 Negative
Triple Negative Breast Cancer
Other: Quality-of-Life Assessment
Drug: Carboplatin

Phase 2

Vanderbilt University Medical Center
Vanderbilt University Medical Center

Nashville, Tennessee, United States and 5 other locations

The purpose of this study is to determine if a combination of two drugs ipatasertib and atezolizumab works as a treatment for residual cancer...

Active, not recruiting
Breast Cancer
Triple Negative Breast Cancer
Drug: Atezolizumab
Drug: Sacituzumab govitecan

Phase 2

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Nashville, Tennessee, United States and 8 other locations

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...

Active, not recruiting
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Trilaciclib
Drug: Placebo

Phase 3

G1 Therapeutics

Nashville, Tennessee, United States and 70 other locations

selective inhibition of phosphoinositide-3-kinase (PI3K)-gamma, in combinations with Tecentriq and Abraxane (nab-paclitaxel) in front-line triple...

Active, not recruiting
Breast Cancer
Renal Cell Carcinoma
Drug: nab-paclitaxel
Drug: Bevacizumab

Phase 2

Infinity Pharmaceuticals
Infinity Pharmaceuticals

Nashville, Tennessee, United States and 23 other locations

avelumab with sacituzumab govitecan works in treating patients with triple negative breast cancer that is stage I...

Enrolling
Stage IIIA Breast Cancer
Recurrent Breast Carcinoma
Biological: Utomilumab
Biological: Anti-OX40 Antibody PF-04518600

Phase 2

Hope Rugo, MD

Nashville, Tennessee, United States and 11 other locations

This study is one single group of participants with non-small cell lung cancer (NSCLC) who have not been cured by other treatments. It is th...

Enrolling
Hormone Receptor Positive Breast Cancer
Non-small Cell Lung Cancer
Drug: Steroid Containing Mouthwash
Other: Non-Steroid Containing Mouthwash

Phase 1

Daiichi Sankyo
Daiichi Sankyo

Nashville, Tennessee, United States and 17 other locations

the efficacy and safety of atezolizumab plus chemotherapy compared with placebo plus chemotherapy in patients with inoperable recurrent triple...

Active, not recruiting
Triple Negative Breast Neoplasms
Drug: Capecitabine
Drug: Atezolizumab

Phase 3

Roche
Roche

Nashville, Tennessee, United States and 137 other locations

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors do no...

Enrolling
Triple Negative Breast Cancer
PD-L1 Negative
Drug: Paclitaxel
Drug: Gemcitabine

Phase 3

Gilead Sciences
Gilead Sciences

Nashville, Tennessee, United States and 506 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors ...

Enrolling
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Paclitaxel

Phase 3

Gilead Sciences
Gilead Sciences

Nashville, Tennessee, United States and 508 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems